{"disease":{"id":"de-novo-liver-transplant-subjects","name":"de novo liver transplant subjects"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01882322","title":"A Study to Evaluate the Effect of Advagraf Conversion From Prograf in Liver Transplant Subjects","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Astellas Pharma Korea, Inc.","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}